These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 22150656)

  • 21. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study.
    Borghi L; Meschi T; Amato F; Briganti A; Novarini A; Giannini A
    J Urol; 1996 Mar; 155(3):839-43. PubMed ID: 8583588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation.
    Koff SG; Paquette EL; Cullen J; Gancarczyk KK; Tucciarone PR; Schenkman NS
    Urology; 2007 Jun; 69(6):1013-6. PubMed ID: 17572176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preventive measures in stones due to infection, uric acid and cystine].
    Hess B; Ackermann D
    Ther Umsch; 1992 Jan; 49(1):44-8. PubMed ID: 1736401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uric acid, phosphate and oxalate stones: treatment and prophylaxis.
    Caramia G; Di Gregorio L; Tarantino ML; Galuffo A; Iacolino R; Caramia M
    Urol Int; 2004; 72 Suppl 1():24-8. PubMed ID: 15133329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up.
    Taylor EN; Stampfer MJ; Curhan GC
    J Am Soc Nephrol; 2004 Dec; 15(12):3225-32. PubMed ID: 15579526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal stone disease and obesity: what is important for urologists and nephrologists?
    Ahmed MH; Ahmed HT; Khalil AA
    Ren Fail; 2012; 34(10):1348-54. PubMed ID: 23013150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors increasing the risk for stone formation in adult patients with cystic fibrosis.
    Terribile M; Capuano M; Cangiano G; Carnovale V; Ferrara P; Petrarulo M; Marangella M
    Nephrol Dial Transplant; 2006 Jul; 21(7):1870-5. PubMed ID: 16595587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substituting milk for apple juice does not increase kidney stone risk in most normocalciuric adults who form calcium oxalate stones.
    Massey LK; Kynast-Gales SA
    J Am Diet Assoc; 1998 Mar; 98(3):303-8. PubMed ID: 9508013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lifestyle recommendations to reduce the risk of kidney stones.
    Meschi T; Nouvenne A; Borghi L
    Urol Clin North Am; 2011 Aug; 38(3):313-20. PubMed ID: 21798393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary factors and kidney stone formation.
    Curhan GC; Curhan SG
    Compr Ther; 1994; 20(9):485-9. PubMed ID: 7805364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diet and nutrition in nephrolitiasis].
    Miggiano GA; Migneco MG
    Clin Ter; 2007; 158(1):49-54. PubMed ID: 17405659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inherited monogenic kidney stone diseases: recent diagnostic and therapeutic advances].
    Jungers P; Joly D; Blanchard A; Courbebaisse M; Knebelmann B; Daudon M
    Nephrol Ther; 2008 Jul; 4(4):231-55. PubMed ID: 18499551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acetazolamide is an effective adjunct for urinary alkalization in patients with uric acid and cystine stone formation recalcitrant to potassium citrate.
    Sterrett SP; Penniston KL; Wolf JS; Nakada SY
    Urology; 2008 Aug; 72(2):278-81. PubMed ID: 18533229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of stone disease.
    Porena M; Guiggi P; Micheli C
    Urol Int; 2007; 79 Suppl 1():37-46. PubMed ID: 17726351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical prevention and treatment of urinary stones.
    Colussi G; De Ferrari ME; Brunati C; Civati G
    J Nephrol; 2000; 13 Suppl 3():S65-70. PubMed ID: 11132035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kidney stones: Composition, frequency and relation to metabolic diagnosis.
    Spivacow FR; Del Valle EE; Lores E; Rey PG
    Medicina (B Aires); 2016; 76(6):343-348. PubMed ID: 27959841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent renal stone disease-advances in pathogenesis and clinical management.
    Bihl G; Meyers A
    Lancet; 2001 Aug; 358(9282):651-6. PubMed ID: 11530173
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.